LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
LLY
1,061.04
+3.27%↑
JNJ
214.42
+1.41%↑
ABBV
227.63
+1.87%↑
UNH
341.44
+0.01%↑
AZN
91.59
+2%↑
24h
Atual
Mín
2.92
Máximo
3.43
Recomendações | Comprar |
|---|---|
Previsão para 12 meses | +223.8% upside |
O desempenho passado não é um indicador confiável de resultados futuros.
15 de dez. de 2025, 16:30 UTC
Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment
DJ
Ler
1 de out. de 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Ler
10 de mar. de 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Ler
10 de mar. de 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Ler
10 de mar. de 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Ler
10 de mar. de 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Ler
10 de mar. de 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Ler
10 de mar. de 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Ler
10 de mar. de 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Ler
Variação de preço
By TipRanks
Previsão para 12 meses
Média 10.75 USD 223.8%
Máximo 17 USD
Mínimo 4.5 USD
Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Fortress Biotech Inc - Dist nos últimos 3 meses.
By TipRanks
Comprar
2 ratings
2
Comprar
0
Manter
0
Vender
Com base em 2 analistas que deram avaliações de ações para Fortress Biotech Inc - Dist nos últimos 3 meses.
$